Suven Pharmaceuticals appointed Mr. Jai Shankar Krishnan as an Independent Director and Mr. Vinod Padikkal as a Non-Executive Director, effective November 12, 2024, pending shareholder approval. The Board also approved the unaudited financial results for the quarter and half-year ended September 30, 2024.